Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/ejcts/ezw305 | DOI Listing |
J Cardiothorac Surg
January 2025
Department of Cardiology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Background: Continuous Positive Airway Pressure (CPAP) treatment brings more benefits than risks to most coronary heart disease (CHD) patients with obstructive sleep apnea (OSA). However, the pathophysiological mechanism by which CPAP treatment improves the prognosis of patients with CHD and OSA remains unclear. The purpose of this study was to clarify whether CPAP can improve arterial stiffness and inflammatory factor levels in CHD patients with OSA, and to further improve prognosis.
View Article and Find Full Text PDFHeart Lung
January 2025
Department of Physical Education, Beijing Wuzi University, Beijing, China. Electronic address:
Background: Chronic Obstructive Pulmonary Disease (COPD) is a common respiratory disease that significantly impairs the quality of life of patients. Single exercises can help COPD patients focus on enhancing specific physical abilities, and enable a more precise analysis of the specific effects of single exercises on improving exercise capacity in COPD patients.
Objectives: To evaluate the effectiveness of single exercises in improving the exercise capacity of COPD patients and to conduct an indirect comparison to identify the most efficacious intervention.
Heart Lung
January 2025
National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address:
Background: Obstructive sleep apnea (OSA) prevalence has risen significantly, affecting millions globally and posing a major healthcare burden. OSA is strongly associated with cardiovascular diseases (CVD) such as heart failure, stroke, and ischemic heart disease. However, trends in CVD-related mortality among individuals with OSA remain underexplored.
View Article and Find Full Text PDFJACC Heart Fail
January 2025
Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address:
BMJ
December 2024
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02120, USA.
Objective: To compare the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once daily dry powder inhaler, in patients with chronic obstructive pulmonary disease (COPD) treated in routine clinical practice.
Design: New user cohort study.
Setting: Longitudinal commercial US claims data.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!